# Example: Allergy List - PACIO Transitions of Care Implementation Guide v1.0.0

* [**Table of Contents**](toc.md)
* [**FHIR Artifacts**](artifacts.md)
* **Example: Allergy List**

## Example AllergyIntolerance: Example: Allergy List

| |
| :--- |
| *Page standards status:*[Informative](http://hl7.org/fhir/R4/versions.html#std-process) |

Profile: [US Core AllergyIntolerance Profile](http://hl7.org/fhir/us/core/STU8.0.1/StructureDefinition-us-core-allergyintolerance.html) version: 8.0.1

**clinicalStatus**: Active

**verificationStatus**: Confirmed

**category**: Medication

**criticality**: High Risk

**code**: Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)

**patient**: [Smith-Johnson, Betsy Female, DoB: 1958-11-01 ( http://hl7.org/fhir/sid/us-medicare#United States Medicare Number#1AA3D58WH16)](Patient-Example-Smith-Johnson-Patient1.md)

**asserter**: [Smith-Johnson, Betsy Female, DoB: 1958-11-01 ( http://hl7.org/fhir/sid/us-medicare#United States Medicare Number#1AA3D58WH16)](Patient-Example-Smith-Johnson-Patient1.md)

**lastOccurrence**: 2011-10

### Reactions

| | | |
| :--- | :--- | :--- |
| - | **Substance** | **Manifestation** |
| * | captopril 12.5 MG Oral Tablet | Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder) |



## Resource Content

```json
{
  "resourceType" : "AllergyIntolerance",
  "id" : "BSJ-AllergyACE",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/us/core/StructureDefinition/us-core-allergyintolerance|8.0.1"]
  },
  "clinicalStatus" : {
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
      "code" : "active"
    }]
  },
  "verificationStatus" : {
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
      "code" : "confirmed"
    }]
  },
  "category" : ["medication"],
  "criticality" : "high",
  "code" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "372733002",
      "display" : "Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)"
    }]
  },
  "patient" : {
    "reference" : "Patient/Example-Smith-Johnson-Patient1"
  },
  "asserter" : {
    "reference" : "Patient/Example-Smith-Johnson-Patient1"
  },
  "lastOccurrence" : "2011-10",
  "reaction" : [{
    "substance" : {
      "coding" : [{
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "308963",
        "display" : "captopril 12.5 MG Oral Tablet"
      }]
    },
    "manifestation" : [{
      "coding" : [{
        "system" : "http://snomed.info/sct",
        "code" : "427195008",
        "display" : "Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)"
      }]
    }]
  }]
}

```
